Cpsf2 - cleavage and polyadenylation specific factor 2 Gene
Also Known as Cpsf; MCPSF; 100kDa; mKIAA1367; 2610024B04Rik
Species: Mus musculus
Summary
Predicted to enable RNA binding activity. Predicted to be involved in mRNA 3'-end processing by stem-loop binding activity and cleavage; mRNA polyadenylation; and pre-mRNA cleavage required for polyadenylation. Predicted to act upstream of or within mRNA processing. Part of mRNA cleavage and polyadenylation specificity factor complex. Orthologous to human CPSF2 (cleavage and polyadenylation specific factor 2). [provided by Alliance of Genome Resources, Apr 2022]
Cpsf2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_016856.3 | NP_058552.1 | cleavage and polyadenylation specificity factor subunit 2 |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| is active in glutamatergic synapse |
IDA
IDA: Inferred from direct assay
|
11980711 | MGI |
| is active in glutamatergic synapse |
IEP
IEP: Inferred from expression pattern
|
11980711 | MGI |
| part of mRNA cleavage and polyadenylation specificity factor complex |
IDA
IDA: Inferred from direct assay
|
16115198 | MGI |
| is active in postsynapse |
IDA
IDA: Inferred from direct assay
|
11980711 | MGI |
| is active in postsynapse |
IEP
IEP: Inferred from expression pattern
|
11980711 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cleavage and polyadenylation specificity factor subunit 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS03117 | CPSF2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service